
HCW Biologics fell 95.8% from $18.36 to $0.77, behind the S&P 500's +13.3%. Its worst day was Mar 23 (−29.9%), and its low came Nov 13 at $0.77.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
HCW Biologics shares rose 79.0%, while the S&P 500 rose 1.0%.
+79.0%, on 77M shares, the year's heaviest volume · S&P 500 +1.0%
Story events cover the past 12 months · Times ET
EPS of $-6.12 missed the $-5.04 estimate on $27,010.00 revenue (est. $7.0M).
−16.7% · S&P 500 +0.8%
EPS of $2.22 beat the $-2.64 estimate on $6.5M revenue.
+262.0%, the year's best day · S&P 500 −1.2%
EPS of $-11.58 missed the $-1.98 estimate on $135,568.00 revenue.
−8.4% · S&P 500 −0.2%
Where it ended: a close of $0.77 on Nov 13, 2026. Up next: Q3 2026 earnings on Nov 27, 2026 (EPS est. $-8.10).
Nothing in the past 12 months.
All HCWB dividend historyReplay the year: the line draws itself and stops at each of the 4 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HCWB and SPY from Benzinga historical bars. Not investment advice.